Hu Xiaochen, Sato Juichi, Oshida Yoshiharu, Xu Ming, Bajotto Gustavo, Sato Yuzo
Department of Sports Medicine, Graduate School of Medicine, Nagoya University, Furo-cho, Chikusa-ku, Japan.
Diabetes Res Clin Pract. 2003 Feb;59(2):103-11. doi: 10.1016/s0168-8227(02)00203-6.
Gosha-jinki-gan (GJG) is a Chinese herbal medicine that is known to be useful for the treatment of diabetic neuropathy. In the present study, the effect of GJG on insulin resistance in streptozotocin (STZ, 50 mgkg(-1) BW, i.v.) -induced diabetic rats was examined by means of the euglycemic clamp procedure. To accomplish this objective, diabetic and non-diabetic control rats were divided as follows: a single dose administration of GJG (800 mgkg(-1) BW, p.o.), saline (5 mlkg(-1) BW, p.o.), and GJG (p.o)+N(G)-monomethyl-L-arginine (L-NMMA, 1 mgkg(-1)min(-1) BW, i.v.). In diabetic rats, the incremental area (DeltaAUC [area under curve]) of the glucose metabolic clearance rate (MCR) during a 3.0 mUkg(-1)min(-1) insulin infusion rate was significantly higher in the GJG-administrated group compared to the saline-administrated one. On the other hand, the effect of GJG on the DeltaAUC of MCR in diabetic rats was abolished by L-NMMA. In addition, no significant differences in the DeltaAUC of MCR were observed in non-diabetic control rats. These results suggest that a single dose administration of GJG can improve the glucose utilization and insulin resistance in STZ-induced diabetic rats, probably via the nitric oxide (NO) pathway.
五苓散(GJG)是一种已知对治疗糖尿病神经病变有用的中药。在本研究中,通过正常血糖钳夹实验研究了GJG对链脲佐菌素(STZ,50mg/kg体重,静脉注射)诱导的糖尿病大鼠胰岛素抵抗的影响。为实现这一目标,将糖尿病和非糖尿病对照大鼠分为以下几组:单次给予GJG(800mg/kg体重,口服)、生理盐水(5ml/kg体重,口服)以及GJG(口服)+N(G)-单甲基-L-精氨酸(L-NMMA,1mg/kg体重·min-1,静脉注射)。在糖尿病大鼠中,与给予生理盐水的组相比,给予GJG的组在胰岛素输注速率为3.0mU/kg体重·min-1时葡萄糖代谢清除率(MCR)的增量面积(ΔAUC[曲线下面积])显著更高。另一方面,L-NMMA消除了GJG对糖尿病大鼠MCR的ΔAUC的影响。此外,在非糖尿病对照大鼠中未观察到MCR的ΔAUC有显著差异。这些结果表明,单次给予GJG可能通过一氧化氮(NO)途径改善STZ诱导的糖尿病大鼠的葡萄糖利用和胰岛素抵抗。